- Home
- STAA vs IRMD Comparison
STAA vs IRMD Comparison
Compare STAA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STAA | IRMD |
|---|---|---|
| Founded | 1982 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | STAA | IRMD |
|---|---|---|
| Price | $21.76 | $89.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $28.00 | ★ $118.00 |
| AVG Volume (30 Days) | ★ 928.5K | 94.3K |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | 0.26 | ★ 0.86 |
| Revenue | ★ $239,442,000.00 | $83,814,000.00 |
| Revenue This Year | $39.61 | $9.85 |
| Revenue Next Year | $7.86 | $13.07 |
| P/E Ratio | ★ $82.69 | $104.24 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $15.59 | $73.02 |
| 52 Week High | $35.87 | $107.90 |
Technical Indicators
Market Signals| Indicator | STAA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 64.03 |
| Support Level | $21.72 | $89.49 |
| Resistance Level | $22.97 | $98.11 |
| Average True Range (ATR) | 0.80 | 2.09 |
| MACD | 0.09 | 0.62 |
| Stochastic Oscillator | 64.83 | 86.18 |
Price Performance
Historical ComparisonAbout STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.